About DrugDev
DrugDev is a Healthcare company based in Wayne (United States) founded in 2008, and was acquired by IQVIA in June 2017. Technology solutions for global clinical trials management are offered. The company has 1 employees. DrugDev has completed 3 acquisitions, including CFS Clinical, Epernicus and TrialNetworks. Its website drugdev.com draws about 68 thousand monthly visits. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is DRUGDEV, INC. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.
Company details
DrugDev is a family of technology driven solutions that help investigators, sponsors, and CROs do more trials together.DrugDev brings together a large active network of clinical trial sites, and an investigator identification and start-up platform, trial optimization system and a grants payment management provider to impact the way drug developers find, engage and pay investigators to run clinical trials. DrugDev is also the host of the Investigator Databank, a global collaboration between Janssen, Lilly, Merck, Pfizer and Novartis (with more companies to come) to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for over 180,000 investigators and to increase visibility of qualified investigators to research sponsors. Its CTMS product is called TrialNetworks. This is a Cloud based platform with unified apps to optimize workflow processes, site engagement and training for global clinical trials.
- Headquarters Wayne, United States
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website drugdev.com
- Social LinkedIn Facebook Instagram
- Acquired by IQVIA (Jun 2017)
- Legal Name Drugdev, Inc.
- Investors
- Employee Count1
- Investments & AcquisitionsCFS Clinical
& 2 more
- Acquired byIQVIA
(Jun 2017)
Investors in DrugDev
DrugDev has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include IQVIA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical research and commercialization solutions are provided for healthcare. | 1982 | iqvia.com | Durham, United States |
Investor details for DrugDev
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DrugDev
1269 people are tracked at DrugDev (701 in leadership, 9 in board & advisors, 559 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Peter Scilipote | Vice President, Business Transformation | Leadership |
Lynda Curtin | Director Clinical Operations -site Management | Leadership |
Oana Borse | Director, Strategic Sourcing R&ds | Leadership |
David Peig | Senior Director - Rare Disease BU & GTM Strategy | Leadership |
Mike Davis | Sr. Director, Strategic Business Development (r&d Solutions) | Leadership |
Ryan Deterding | Vice President And Global Account Director | Leadership |
Iqbal Thaker | Assoc. Director - IT Projects | Leadership |
Jennifer Millard | Vice President | Leadership |
Arthur Jenkins | Senior Director, Porfolio Project Management And Development Engineering | Leadership |
Manoj Singh | Director Of Software Engineering | Leadership |
Ester Pavon | Associate Director, Clinical Project Management | Leadership |
Nuno Dias | Senior Director, IT (head Of Technology) | Leadership |
Alexey Levashov | Associate Clinical Project Management Director | Leadership |
Chris Nickum | Vice President And General Manager, Commercial Solutions And Insights Hub (csih) | Leadership |
Fumihiko Ugajin | President - Japan | Leadership |
Stormie R. Crouch | Senior Director, Business Development | Leadership |
Avery Pasch | Account Director | Leadership |
Abbygail Boswell | International Project Associate Director | Leadership |
Susan Grant Schneider | Senior Vice President | Leadership |
Melissa Daily | Associate Director, Human Resources | Leadership |
1249 more people are available in the full profile.
Complete people profiles for DrugDev
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DrugDev
DrugDev has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include CFS Clinical, Epernicus and TrialNetworks.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based collaborative apps for clinical trial management are provided. | trialnetworks.com | Needham, United States | 2008 | May 2014 | •••• | |
Social networking is provided for researchers and clinical trials. | epernicus.com | Cambridge, United States | 2007 | May 2014 | •••• | |
Technology solutions for clinical trial financial management are provided. | cfsclinical.com | Philadelphia, United States | 2001 | Oct 2013 | •••• |
Complete acquisition details for DrugDev
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of DrugDev
5 dated milestones of DrugDev across 9 years, from founding to its latest funding, stage changes and deals.
- Founded DrugDev is founded.
- Acquisition Acquires CFS Clinical.
- Acquisition Acquires TrialNetworks.
- Acquisition Acquires Epernicus.
- Exit Acquired by IQVIA.
Competitors of DrugDev
DrugDev has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. |
Detailed competitors of DrugDev
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DrugDev
The website of DrugDev (drugdev.com) receives about 67.8K visits a month and ranks #394,005 among all websites worldwide, #341 in Biotechnology and Pharmaceuticals.
- Monthly visits67.8K
▲ 7.7% vs previous month
- Unique visitors16.5K
per month
- Global rank#394,005
among all websites
- Category rank#341
Health · Biotechnology and Pharmaceuticals
- Bounce rate32%
- Pages per visit5.7
- Average visit2 min 28 sec
- DevicesDesktop 73% · Mobile 27%
Websites whose visitors overlap most with DrugDev. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cirbi.net | cirbi.net | 100% | #187,438 | – | |
abbvie.sharepoint.com | abbvie.sharepoint.com | 97% | – | ||
clincard.com | clincard.com | 60% | #362,289 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as DrugDev (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DrugDev
DrugDev was founded in 2008.
DrugDev is headquartered in Wayne, United States.
DrugDev has 1 employees.
DrugDev is a family of technology driven solutions that help investigators, sponsors, and CROs do more trials together.DrugDev brings together a large active network of clinical trial sites, and an investigator identification and start-up platform, trial optimization system and a grants payment management provider to impact the way drug developers find, engage and pay investigators to run clinical trials. DrugDev is also the host of the Investigator Databank, a global collaboration between Janssen, Lilly, Merck, Pfizer and Novartis (with more companies to come) to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for over 180,000 investigators and to increase visibility of qualified investigators to research sponsors. Its CTMS product is called TrialNetworks. This is a Cloud based platform with unified apps to optimize workflow processes, site engagement and training for global clinical trials.
DrugDev has made 3 acquisitions, including CFS Clinical, Epernicus, and TrialNetworks.
DrugDev has 1 investor. Key investors include IQVIA.
DrugDev operates through Drugdev, Inc..
Yes. DrugDev was acquired by IQVIA in June 2017.